NewAmsterdam Pharma Company had a revenue of 2.98M in the quarter ending Mar 31, 2025, with -76.68%. This bring the company's revenue in the last twelve months to 47.14M, Decreased 3.46%. In the fiscal year ending Dec 31, 2024, NewAmsterdam Pharma Company had annual revenue of 45.56M with 257.00% growth.